Job Creation Roars Back, Labor Secretary Mart...

The Supreme Court ruling 6-3 AGAINST President Trump's tariffs: Hear a jam-packed hour of analysis from Carl Quintanilla, Sara Eisen, and David Faber - spanning key takeaways, the market impact, what happens to any refunds, China's quiet win between the lines, and breakouts acros ...  Show more

Cramer says this retail stock is a buy after SCOTUS strikes down President Trump’s tariffs. This episode contains a preview of exclusive content from the members-only CNBC Investing Club morning meeting. Become an Investing Club member to go behind the scenes with Jim Cramer and ...  Show more

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ...

Former FDA chief Dr. Scott Gottlieb hopes the rate of Covid-19 infections in New York will start to slow next week, but wildcards like Texas and Florida could push the nation’s death toll close to the President’s sobering new estimates. Eurasia Group’s Ian Bremmer explains whe ...

The market today had a mixed bag day, with the S&P 500 and the NASDAQ falling while the Dow Jones Industrial Average gained 80 points, and Jim Cramer is digging into factors impacting the market this week. First, Jim sits down with Conagra CEO Sean Connolly to discuss the driv ...

DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...  Show more